BSECompany Update25 Aug 2026 · 25 Aug 2026, 03:01 pm

Transcript of Conference Call with Investors and Analysts held on August 18, 2026

Mitsu Chem Plast Ltd · 540078

✦ AI Summary▲ PositiveResults

Mitsu Chem Plast Ltd reported strong Q1 FY27 earnings, with 11.62% yoy growth in total income, 209.50% yoy increase in EBITDA, and 566.23% yoy growth in net profit. The company also announced a proposed expansion of its manufacturing capacity by 3,550 metric tons per annum.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment9/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mitsu Chem Plast Ltd - 540078 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Attachments (1)

📄

146c8746-fd2e-4527-8b88-5de3b019c2c3.pdf

pdf

Download →
View document text
Date: August 25, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street Mumbai- 400001 Scrip Code : 540078 Sub: Transcript of Conference Call with Investors and Analysts held on August 18, 2026 Dear Sir/Madam, With reference to our previous communication dated August 13, 2026 intimating you about the Conference Call with Investors and Analysts held on August 18, 2026, please find attached transcript of the aforesaid Conference Call. Kindly take the same on record. Thanking you. Yours truly, FOR MITSU CHEM PLAST LIMITED Gargi Sawant Company Secretary & Compliance Officer Encl: as above “Mitsu Chem Plast Limited Q1 FY27 Earnings Conference Call” August 18, 2026 MANAGEMENT: MR. MANISH DEDHIA – MANAGING DIRECTOR AND CHIEF FINANCIAL OFFICER – MITSU CHEM PLAST LIMITED MS. KASHMIRA DEDHIA – VICE PRESIDENT – FINANCE AND ACCOUNTS – MITSU CHEM PLAST LIMITED MODERATOR: MR. KARAN THAKUR – KIRIN ADVISORS PRIVATE LIMITED Page 1 of 16 Mitsu Chem Plast Limited August 18, 2026 Moderator: Ladies and gentlemen, good day, and welcome to Mitsu Chem Plast Limited Q1 FY27 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing star then zero on your touchphone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Karan Thakur from Kirin Advisors. Thank you, and over to you, sir. Karan Thakur: Thank you. On behalf of Kirin Advisors, I welcome you all to the conference call of Mitsu Chem Plast Limited. From the management team, we have Mr. Manish Dedhia, Managing Director and Chief Financial Officer; and Ms. Kashmira Dedhia, Vice President, Finance and Accounts. With that now, I hand over the call to Mr. Manish Dedhia for opening remarks. Over to you, sir. Manish Dedhia: Thank you. Good afternoon, everyone. It is a pleasure to welcome all investors, analysts and participants to the Mitsu Chem Plast Limited Q1 FY27 Earnings Conference Call. We sincerely appreciate your continued support and interest in our company. Q1 FY27 reflected continued progress for Mitsu Chem Plast Limited with focus on strengthening our manufacturing capabilities, improving operational efficiencies and supporting growth across our diversified product portfolio. During the quarter, the company continued to build on its capabilities across industrial packaging, health care, infrastructure and other value-added applications. We are also pleased to announce a proposed addition of 3,550 metric tons per annum to our existing manufacturing capacity of 32,450 metric ton per annum overall. This expansion is aimed at strengthening our ability to cater to growing demand across key products segments and supporting the company's long-term growth plan. Our existing capacity utilization stood at 64% in FY26, providing a strong base for further product and capacity expansion. Our diversified product portfolio continues to remain a key strength. We operate across blow molding, injection molding and custom molding applications, serving industries, including pharmaceuticals, chemicals, agrochemical, FMCG, food, health care and other industrial segments. The company currently operates four manufacturing facilities with 53 blow molding machines and 22 injection molding machines and installed capacity of more than 32,450 metric tons per annum. Healthcare furniture remains an important growth opportunity for the company through our Furnastra brand. Furnastra is focused on innovative and durable hospital furniture components with an emphasis on quality, ergonomic design and customer-centric solutions. We continue to see opportunity to strengthen this vertical and expand its market presence. Page 2 of 16 Mitsu Chem Plast Limited August 18, 2026 Our packaging portfolio also remains an important area of focus with continued emphasis on products such as paint containers, jerry cans and specialized caps and closures. This initiative are aligned with our broader transformation strategy focused on operational excellence, data- driven marketing, scientific innovation and empowered teams. This company also continued to maintain a strong export presence across 17 countries, supported by a diversified customer base across pharmaceutical, health care, chemical, FMCG and other industries. Our in-house R&D design and value engineering capabilities further support our ability to develop customized and value-added solutions for customers. The company delivered a strong financial performance during Q1 FY 2027. Total income grew 11.62% year-on-year, while EBITDA increased by 209.50%, supported by improved operating efficiencies and a stronger product mix. Net profit increased by 566.23% year-on-year, reflecting a significant improvement in overall profitability. Going forward, our focus remains on expanding manufacturing capacity, strengthening our product portfolio, improving operational efficiencies and leveraging opportunities across industrial and packaging segments. We remain committed to building sustainable growth and creating long-term value for all our stakeholders. Before concluding, I would like to thank our employees, customers, business partners and shareholders for their continued trust and support. With this, I conclude my remarks and I now request Ms. Kashmira Dedhia to take you through the financial performance for the quarter ended June 30, 2026. Kashmira Dedhia: Thank you. Good afternoon, everyone. I will now take you through the financial highlights for quarter 1 FY27. For the first quarter of financial year '27, Mitsu Chem Plast Limited reported strong improvement in profitability, supported by better operating efficiency and improved product mix. Total income for the quarter stood at INR 9,532.78 lakhs, registering a growth of 11.62% year- on-year compared to INR 8,540.39 lakhs in quarter 1 FY2026. EBITDA increased significantly to INR 1,549.48 lakhs, registering a growth of 209.50% year-on-year. EBITDA margin improved to 16.29% compared to 5.87% in quarter 1 FY26 representing an expansion of 1041 basis points. Net profit for quarter 1 FY27 stood at INR 873.83 lakhs, registering a growth of 566.23% year- on-year compared to INR 131.16 lakhs in quarter 1 FY26. Net profit margin improved to 9.18% compared to 1.54% in the corresponding quarter last year. Earnings per share for the quarter stood at INR 6.44 compared to INR 0.97 in quarter 1 FY26. On a sequential basis, the company also continued to maintain strong profitability. EBITDA stood at INR 1,549.48 lakhs in quarter 1 FY27 compared to INR 1,422.74 lakhs in quarter 4 FY26, while net profit increased from INR 771.73 lakhs in quarter 4 FY26 to INR 873.83 lakhs in quarter 1 FY27. Page 3 of 16 Mitsu Chem Plast Limited August 18, 2026 The strong improvement in EBITDA and net profit reflects the benefit of improved operating efficiency and a stronger product mix during the quarter. Looking ahead, our priority remains focused on capacity expansion, strengthening our diversified product portfolio and improving operational efficiency. The proposed addition of 3,550 metric ton per annum to our existing capacity will provide additional manufacturing capabilities to support growth across key product verticals. We will continue to focus on higher value-added opportunities across packaging, health care furniture and other industrial applications. Our transformation agenda remains cantered around Furnastra, enhanced packaging products, operational excellence, data-driven marketing, scientific innovation and empowered teams. The company continues to work towards its long-term objective of achieving INR 1,000 crores in annual revenue by FY28. With that, I conclude my financial update. I will now request the moderator to open the floor for question-and-answers. Thank you. Moderator: Thank you very much. We will no [Showing first 8,000 characters — download PDF for full document]